Picture of SymBio Pharmaceuticals logo

4582 — SymBio Pharmaceuticals News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: SymBio Pharmaceuticals - 6-MTH group results

Aug 4 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Jun 30, 2022        Jun 30, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               4.87                                 10.00    
  Operating           1.37                                  1.77    
  Recurring           1.45                                  1.75    
  Net                 1.11                                  1.48    
  EPS               28.71 yen                            38.35 yen  
  EPS Diluted       28.32 yen                                       
  Ann Div                                  NIL              NIL     
  -Q2 div              NIL                 NIL                      
  -Q4 div                                  NIL              NIL     
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T

Recent news on SymBio Pharmaceuticals

See all news